Bioorganic and Medicinal Chemistry Letters p. 3652 - 3657 (2018)
Update date:2022-07-31
Topics:
Ashraf-Uz-Zaman, Md
Sajib, Md Sanaullah
Cucullo, Luca
Mikelis, Constantinos M.
German, Nadezhda A.
Several recent reports have highlighted the feasibility of the use of penfluridol, a well-known antipsychotic agent, as a chemotherapeutic agent. In vivo experiments have confirmed the cytotoxic activity of penfluridol in triple-negative breast cancer model, lung cancer model, and further studies have been proposed to assess its anticancer activity and viability for the treatment of glioblastomas. However, penfluridol anticancer activity was observed at a dosage significantly higher than that administered in antipsychotic therapy, thus raising the concern for the potential onset of CNS side effects in patients undergoing intensive pharmacological treatment. In this study, we evaluate the potential CNS toxicity of penfluridol side by side with a set of analogs.
View MoreHunan Dinuo Pharmaceutical Co.,Ltd.
Contact:86-731-88280100*8561
Address:Bio-pharmaceutical industrial park, Liuyang, Hunan, China
Jiacheng-Chem Enterprises Limited
Contact:86-571-86711508
Address:19 Floor, CIBC Holley International Building, No. 198,Wuxing Road, Hangzhou, China,310020
Contact:86-513-84128750/13773795976
Address:No.48.Youyi West Road ,Rudong Development Zone,Jiangsu Province,China
Jining Shengrun Chemical Industry Co., Ltd.
Contact:+86-537-7121666 ,
Address:West Ring Road,Wenshang County Shandong Province
ShangHai Original Economy-Trade Develop Co.,Ltd.,
Contact:86-21-68552131
Address:shanghai
Doi:10.1002/zaac.201000228
(2011)Doi:10.1021/ja00167a096
(1990)Doi:10.1021/ol1030316
(2011)Doi:10.1021/ja200089f
(2011)Doi:10.1007/BF00962133
(1989)Doi:10.1080/10426501003767110
(2011)